Entheon Biomedical Corp. (CSE:ENBI)

Canada flag Canada · Delayed Price · Currency is CAD
0.1450
+0.0200 (16.00%)
Mar 28, 2025, 1:07 PM EST
45.00%
Market Cap 2.01M
Revenue (ttm) n/a
Net Income (ttm) -317.92K
Shares Out 13.86M
EPS (ttm) -0.04
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 23,200
Average Volume 14,973
Open 0.1400
Previous Close 0.1250
Day's Range 0.1400 - 0.1450
52-Week Range 0.0750 - 0.4500
Beta 1.35
RSI 35.16
Earnings Date Mar 21, 2025

About Entheon Biomedical

Entheon Biomedical Corp. operates as a biotechnology research and development company. It develops products for treating addiction and substance use disorders. The company is headquartered in Vancouver, Canada. [Read more]

Industry Biotechnology
Sector Healthcare
CEO Timothy Ko
Employees 1
Stock Exchange Canadian Securities Exchange
Ticker Symbol ENBI
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.